Korea tightens clinical trials control:
This article was originally published in Clinica
Executive Summary
All clinical trials in Korea, large or small, will need the prior approval of the Korean FDA, as of February 14 2002, when the revised pharmaceutical affairs law takes effect, reports Pharma Koreana. This aspect of the law amendment, decided on August 14 2001, is designed to provide better patient protection.